What is LungLife AI, Inc. (LLA.L)?

LungLife AI, Inc. (LLA.L) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

LungLife AI, Inc. (LLA.L)

Stock analysis · LSE · Healthcare · Medical - Diagnostics & Research

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.35

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

LungLife AI, Inc. (LLA.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About LungLife AI, Inc.

Headquartered in Thousand Oaks, California, and established in 2009, LungLife AI, Inc. is a diagnostics firm dedicated to creating AI-powered clinical solutions for lung cancer. The company, which was known as Cynvenio Biosystems, Inc. until its renaming in May 2019, operates in both the United States and China. Its primary focus involves the ongoing development of LungLB, a blood test engineered to differentiate between cancerous and non-cancerous lung nodules initially discovered through CT scans.